** Hikma Pharmaceuticals, up 3.7 pct and close totesting all-time high again after two 5-star rated brokers issuebullish recommendations on stock.
** Stock is Europe's best performing small-cap,extends 2014's stellar run that saw stock up 66.8 pct.
** JPMorgan lifts its PT on stock by 18.4 pct, keeps"overweight" rating, while Jefferies upgrades stock to a "buy"
** Jefferies expects momentum to continue into 2015 andexpects company to prevail in ongoing legal case vs Takeda over co's respective gout treatment drugs.
** Hikma currently trading at 22.7 times forward earnings, athird above its historical median since listing in 2006. (RM: vikram.subhedar.thomsonreuters.com@reuters.net)